Prof Fidelma Dunne
Fidelma Dunne holds a Personal Professorship in Medicine at the National University of Ireland. In addition she is a Consultant Endocrinologist at Galway University Hospitals group. She obtained her medical degree from the National University of Ireland Galway (NUIG), her MD from University College Cork, her PhD from the University of Birmingham UK and also holds a Masters in Medical Education from the University of Dundee Scotland and a Masters in Clinical Research from NUIG. She is a former Dean of the School of Medicine (2009-2013) and currently is a board member of the Irish Medical Council (IMC)(2013-present).
Her major research interest is in the area of pregnancy and diabetes. She has published >200 peer review publications and has received >15m euro in grant funding either as PI or collaborator of national and international projects. Her research group are conducting a number of studies as part of the ATLANTIC DIP programme including a randomized controlled trial (RCT) of Metformin in GDM pregnancies (EMERGE).
In addition, she has been involved in a number of international studies including a multicentre European funded (FP7) trial on prevention of GDM using Vitamin D and lifestyle intervention (DALI), CONCEPTT a JDRF funded trial examining the benefits of CGMS in women with Type 1 Diabetes during pregnancy and EVOLVE a pan European collection of outcomes for women with Type 1 and Type 2 diabetes treated with insulin. She is currently contributing to the EXPECT study examining Tresiba insulin in women with Type 1 Diabetes in pregnancy.
Professor Dunne is the only Irish committee member of the Diabetes in Pregnancy Study Group (DPSG) of EASD and is the current President of the International Diabetes in Pregnancy Study Groups (IADPSG) from 2016-2020. She was a Fulbright scholar for 2014-2015 at Columbia University New York.